Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA